Clinical trial
INTEnsive Ambulance-delivered Blood Pressure Reduction in Biomarker-identified Hyper-ACute Intracerebral Haemorrhage Trial - Validation Study
NCT07231315 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- INTEnsive Ambulance-delivered Blood Pressure Reduction in Biomarker-identified Hyper-ACute Intracerebral Haemorrhage Trial - Validation Study
- Lead sponsor
- The George Institute
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- February 1, 2026
- Completion date
- June 1, 2027
- Enrollment
- 465 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
intracerebral hemorrhage